A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Summary

The purpose of this study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo for the treatment of patients with hallucinations and delusions associated with Alzheimer's disease.

Timeline

Start

2002-03

Primary completion

—

Completion

2003-03

Outcome

Outcome not reported

Stopped (Business): “A decision was made to discontinue the study due to a change in the strategic direction of the company.”

Drugs

Indications